Patents by Inventor Rose Ackermann
Rose Ackermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250302916Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: June 11, 2025Publication date: October 2, 2025Applicant: ABIONYX PHARMA SAInventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Patent number: 12364735Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: May 27, 2022Date of Patent: July 22, 2025Assignee: ABIONYX PAHRMA SAInventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
-
Patent number: 11998587Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: August 4, 2023Date of Patent: June 4, 2024Assignee: Abionyx Pharma SAInventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
-
Patent number: 11969456Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: August 4, 2023Date of Patent: April 30, 2024Assignee: Abionyx Pharma SAInventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
-
Publication number: 20240000887Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: August 4, 2023Publication date: January 4, 2024Applicant: ABIONYX PHARMA SAInventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Publication number: 20230372441Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: August 4, 2023Publication date: November 23, 2023Applicant: ABIONYX PHARMA SAInventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Publication number: 20220362336Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: May 27, 2022Publication date: November 17, 2022Applicant: ABIONYX PHARMA SAInventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Patent number: 11376309Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: April 29, 2019Date of Patent: July 5, 2022Assignee: Cerenis Therapeutics Holding S.A.Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
-
Publication number: 20190298800Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: April 29, 2019Publication date: October 3, 2019Applicant: CERENIS THERAPEUTICS HOLDING S.A.Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Patent number: 10328119Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: July 17, 2014Date of Patent: June 25, 2019Assignee: CERENIS THERAPEUTICS HOLDING S.A.Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
-
Patent number: 10322163Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: October 15, 2015Date of Patent: June 18, 2019Assignee: CERENIS THERAPEUTICS HOLDING S.A.Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
-
Publication number: 20160095901Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: October 15, 2015Publication date: April 7, 2016Applicant: CERENIS THERAPEUTICS HOLDING S.A.Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Patent number: 9187551Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: GrantFiled: December 11, 2013Date of Patent: November 17, 2015Assignee: Cerenis Therapeutics Holding S.A.Inventors: Jean-Louis Dasseux, Rose Ackermann
-
Publication number: 20150152164Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: July 17, 2014Publication date: June 4, 2015Inventors: Jean-Louis DASSEUX, Rose Ackermann, Daniela Carmen Oniciu
-
Publication number: 20140213501Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: December 11, 2013Publication date: July 31, 2014Applicant: Cerenis Therapeutics Holding S.A.Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
-
Publication number: 20120232005Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.Type: ApplicationFiled: February 6, 2012Publication date: September 13, 2012Applicant: Cerenis Therapeutics Holding S.A.Inventors: Jean-Louis Dasseux, Daniela Carmen Oniciu, Rose Ackermann